The results of the GlucAffect® clinical trial, which took place last year, have now been published in the journal Phytotherapy Research and are available for download on the Relìv website. Just select “blood sugar management” under the “Products” tab of reliv.com and choose the link to the study.Overview:
In the eight-week clinical study, 50 overweight subjects with moderately elevated fasting blood glucose — criteria for metabolic syndrome — were randomly assigned to either receive four daily servings of GlucAffect nutritional supplement or an inactive control product with identical taste, color and texture as a meal replacement. They also agreed to participate in a diet and exercise program.
Test subjects taking GlucAffect lowered their blood fasting glucose by an average of 30%, moving from elevated glucose levels to healthy blood sugar values. The lowered blood glucose was confirmed by the average HbA1c (glycosylated hemoglobin) level, which also moved into the healthy range. No significant glucose lowering was found in the control group.
In addition, those individuals taking GlucAffect lost an average of nearly 16 pounds during the eight-week period, slimming to an extent on average that they achieved their optimal BMI (body mass index). No significant effect on body weight was found in the control group.
That’s real science producing real results — that’s Relìv.
Download the study now and let the world know that GlucAffect offers a proven approach to address one of our nation’s most urgent health care needs.
